Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de Adaptive Biotechnologies Corp?

Accepted Answer

Según el último estado financiero (Form-10K), Adaptive Biotechnologies Corp tiene un total de activos de $539, una ganancia neta loss de $-159

Question 2

¿Cuáles son los ratios financieros clave para ADPT?

Accepted Answer

El ratio corriente de Adaptive Biotechnologies Corp es 1.6, el margen neto es -89.32, las ventas por acción son $1.21.

Question 3

¿Cómo se desglosan los ingresos de Adaptive Biotechnologies Corp por segmento o geografía?

Accepted Answer

Adaptive Biotechnologies Corp largest revenue segment is Minimal Residual Disease - Service, at a revenue of 133,029,000 in the most earnings release.For geography, United States is the primary market for Adaptive Biotechnologies Corp, at a revenue of 178,957,000.

Question 4

¿Es rentable Adaptive Biotechnologies Corp?

Accepted Answer

no, según los últimos estados financieros, Adaptive Biotechnologies Corp tiene una ganancia neta loss de $-159

Question 5

¿Tiene Adaptive Biotechnologies Corp alguna deuda?

Accepted Answer

yes, Adaptive Biotechnologies Corp tiene una deuda de 336

Question 6

¿Cuántas acciones en circulación tiene Adaptive Biotechnologies Corp?

Accepted Answer

Adaptive Biotechnologies Corp tiene un total de acciones en circulación de 147.77

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	252	178	170	185	154	98
Revenue Growth (YoY)	42%	5%	-8%	20%	56.99%	15%
Cost of Revenue	71	72	75	57	49	22
Gross Profit	181	106	94	127	105	75
Selling, General & Admin	163	157	172	183	170	110
Research & Development	85	94	109	122	142	116
Operating Expenses	259	262	296	326	314	228
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-79	-159	-225	-200	-207	-146
Income Tax Expense	--	--	--	--	--	--
Net Income	-79	-159	-225	-200	-207	-146
Net Income Growth	-59%	-28.99%	13%	-3%	42%	112%
Shares Outstanding (Diluted)	163.16	147.1	144.38	142.5	140.4	131.2
Shares Change (YoY)	10%	2%	1%	2%	7%	5%
EPS (Diluted)	-0.48	-1.08	-1.56	-1.4	-1.48	-1.11
EPS Growth	-64%	-31%	11%	-5%	33%	98%
Free Cash Flow	-62	-98	-167	-200	-254	-168
Free Cash Flow Per Share	-0.37	-0.66	-1.15	-1.4	-1.8	-1.28
Gross Margin	71.82%	59.55%	55.29%	68.64%	68.18%	76.53%
Operating Margin	-30.95%	-87.07%	-118.23%	-107.02%	-135.71%	-155.1%
Profit Margin	-31.34%	-89.32%	-132.35%	-108.1%	-134.41%	-148.97%
Free Cash Flow Margin	-24.6%	-55.05%	-98.23%	-108.1%	-164.93%	-171.42%
EBITDA	-67	-145	-187	-178	-208	-151
EBITDA Margin	-26.58%	-81.46%	-110%	-96.21%	-135.06%	-154.08%
D&A For EBITDA	11	10	14	20	1	1
EBIT	-78	-155	-201	-198	-209	-152
EBIT Margin	-30.95%	-87.07%	-118.23%	-107.02%	-135.71%	-155.1%
Effective Tax Rate	--	--	--	--	--	--

Adaptive Biotechnologies Corp (ADPT) Price

ADPT Stock Price Chart

ADPT Income

Follow-Up Questions